Burkhard Blank
2021
In 2021, Burkhard Blank earned a total compensation of $1.4M as Former Chief Medical Officer and Head of R&D at Acorda Therapeutics, a 67% increase compared to previous year.
Compensation breakdown
| Bonus | $289,050 |
|---|---|
| Salary | $533,100 |
| Stock Awards | $69,976 |
| Other | $541,800 |
| Total | $1,433,926 |
Blank received $541.8K in other compensation, accounting for 38% of the total pay in 2021.
Blank also received $289.1K in bonus, $533.1K in salary and $70K in stock awards.
Rankings
In 2021, Burkhard Blank's compensation ranked 7,442nd out of 12,415 executives tracked by ExecPay. In other words, Blank earned more than 40.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,442 out of 12,415 | 40th |
Division Manufacturing | 3,273 out of 5,508 | 41st |
Major group Chemicals And Allied Products | 1,447 out of 2,378 | 39th |
Industry group Drugs | 1,288 out of 2,099 | 39th |
Industry Biological Products, Except Diagnostic Substances | 297 out of 449 | 34th |
Pay ratio
| Burkhard Blank's Pay | $1,433,926 |
|---|---|
| Median Employee's Pay | $226,642 |
| Pay Ratio | 6to 1 |
In 2021, the annual total compensation of Burkhard Blank was $1,433,926.
The annual total compensation of the median employee at Acorda Therapeutics was $226,642.
The ratio of Burkhard Blank's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 28, 2022.
Blank's colleagues
We found four more compensation records of executives who worked with Burkhard Blank at Acorda Therapeutics in 2021.
News
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019